Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Gat Pozner
Institution:
Teva Pharmaceuticals (Israel)
Observed institutions:
Hachaklait (Israel),
Teva Pharmaceuticals (Israel)
ORCID:
0000-0003-0452-9043
Observed ORCID:
0000-0003-0452-9043
OpenAlex ID:
A5002509035
Mitochondrial augmentation of hematopoietic stem cells in children with single large-scale mitochondrial DNA deletion syndromes
2022
·
Elad Jacoby
, Omer Bar-Yosef
, et al.
·
Science Translational Medicine
·
83
Mitochondrial augmentation of CD34+ cells from healthy donors and patients with mitochondrial DNA disorders confers functional benefit
2021
·
Elad Jacoby
, Moriya Ben Yakir-Blumkin
, et al.
·
npj Regenerative Medicine
·
33
PDF
Therapeutic potential of mitochondrial transplantation in the treatment of MDS
2025
·
Takeshi Fujino
, Tina Napso
, et al.
·
Blood
PDF
Mitochondrial Augmentation of Hematopoietic Stem and Progenitor Cells As a New Therapeutic Approach for Myelodysplasia
2024
·
Takeshi Fujino
, Noa Avni
, et al.
·
Blood
Show more works
View as search
Works count:
4
Citation count:
116
H-index:
2
I10-index:
2
Year
Topic
Type
